When was Mestinon approved by the FDA?

Written by Marta Figueiredo, PhD |

A

When was Mestinon approved by the FDA?

Category: Mestinon

The U.S. Food and Drug Administration (FDA) approved Mestinon in 1955 as an oral tablet for the treatment of myasthenia gravis. Other formulations have been developed since then, including extended-release tablets, syrups, and injectable forms.

Print This Article
Marta Figueiredo, PhD avatar

About the Author

Marta Figueiredo, PhD Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology, and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — those that make up the lining of blood vessels — found in the umbilical cord of newborns. In addition to several research fellowships, she was awarded two Erasmus scholarships to conduct part of her studies in France. She has also authored several research papers published in peer-reviewed international scientific journals. Joana joined Bionews in 2018, starting as a science writer, then moving to a science editor position in 2020, and to editorial associate director of resource pages in 2025.